BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19906272)

  • 1. The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes.
    Furundarena JR; Araiz M; Uranga M; Sainz MR; Agirre A; Trassorras M; Uresandi N; Montes MC; Argoitia N
    Int J Lab Hematol; 2010 Jun; 32(3):360-6. PubMed ID: 19906272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Utility of XE-2 100 Analyzer's NEUT-X and NEUT-Y Parameters for Detecting Neutrophil Dysplasia in Myelodysplastic Syndromes].
    Isono S; Okamur A; Iwamoto M; ImaiJunko IMAI ; Nagata K; Akishino T; Okamura A; Kawamoto S; Kono M; Sugimoto T; Saigo K
    Rinsho Byori; 2016 Jan; 64(1):21-6. PubMed ID: 27192792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100™.
    Le Roux G; Vlad A; Eclache V; Malanquin C; Collon JF; Gantier M; Schillinger F; Peltier JY; Savin B; Letestu R; Baran-Marszak F; Fenaux P; Ajchenbaum-Cymbalista F
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e237-43. PubMed ID: 20670338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.
    Miguel A; Orero M; Simon R; Collado R; Perez PL; Pacios A; Iglesias R; Martinez A; Carbonell F
    Lab Hematol; 2007; 13(3):98-102. PubMed ID: 17984041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of neut-X, neut-Y and neut-Z parameters for rapidly assessing sepsis in tumor patients.
    Luo Y; Lin J; Chen H; Zhang J; Peng S; Kuang M
    Clin Chim Acta; 2013 Jun; 422():5-9. PubMed ID: 23545278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantification of hypo- and hypergranulated neutrophils on the new Sysmex XN hematology analyzer: establishment of an adapted reference interval for the neutrophil-granularity-intensity compared to XE-technology in adult patients.
    Zimmermann M; Steenhuis P; Linssen J; Weimann A
    Clin Lab; 2015; 61(3-4):235-41. PubMed ID: 25974988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes.
    Hast R; Nilsson I; Widell S; Ost A
    Leuk Res; 1989; 13(2):173-8. PubMed ID: 2927174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picking up myelodysplastic syndromes and megaloblastic anemias on peripheral blood: use of NEUT-X and NEUT-Y in guiding smear reviews.
    Goel S; Sachdev R; Gajendra S; Jha B; Sahni T; Dorwal P; Srivastava C; Tiwari AK; Sood N; Gupta S; Raina V; Vaid AK
    Int J Lab Hematol; 2015 Apr; 37(2):e48-51. PubMed ID: 25132616
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of diagnosis of patients with myelodysplastic syndromes by routine laboratory parameters].
    Li L; Nie L; Yu MH; Zheng YZ; Zhang Y; Xu ZF; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):623-8. PubMed ID: 19175993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
    Cantù Rajnoldi A; Fenu S; Kerndrup G; van Wering ER; Niemeyer CM; Baumann I;
    Ann Hematol; 2005 Jul; 84(7):429-33. PubMed ID: 15838669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndromes].
    Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
    Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
    Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of NeuX and NeuZ can predict neutrophil dysplasia features of myelodysplastic neoplasms in peripheral blood.
    Sun P; Li N; Zhang S; Liu S; Zhang H; Yue B
    Int J Lab Hematol; 2023 Aug; 45(4):522-527. PubMed ID: 36922282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.